Micallef Jacob Vincent, Chief Scientific Officer at VOLITIONRX LTD (VNRX), sold 5,850 shares on October 04, 2025, at an average price of $0.65, realizing proceeds of about ~$3,790.80. Despite the sale, he retains 393,089 direct shares and 93,113 indirect shares. For retail traders, this is a neutral event: routine tax-withholding disposition rather than an opportunistic open-market sale.
Decide: Neutral
Neutral. The filings show code F tax-withholding dispositions (issuer retained shares to satisfy withholding) with small proceeds relative to holdings โ a routine, comp-related event rather than a discretionary sell signal. Data completeness is high for this transaction, but cluster activity cannot be determined from this filing alone.
This transaction looks like routine tax-withholding rather than a bearish signal. For retail traders, itโs noise, not a tradeable event โ not worth short-/mid-term action unless corroborated by sales from VolitionRxโs CEO, CFO, or multiple insiders.